Spandan Chaudhary has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Supplemental Table 3 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study

    by Krithiga Shridhar, Arvind Krishnamurthy, Vijayalakshmi Ramshankar, Siddhartha Mandal, Toral Vaishnani, Spandan Chaudhary, Aastha Aggarwal, Rupak Shivakoti

    Supplemental Table 3. Log Fold change (LFC) in differential abundance of established periodontal pathogens by tongue cancer cases (N = 31) and cancer-free controls (N = 31).

  • Open Access

    Data from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study

    by Krithiga Shridhar, Arvind Krishnamurthy, Vijayalakshmi Ramshankar, Siddhartha Mandal, Toral Vaishnani, Spandan Chaudhary, Aastha Aggarwal, Rupak Shivakoti

    Evidence for the role of oral microbiota in tongue cancers is limited despite early-onset and unexplained etiology. We assessed oral microbiota profiles in saliva among participants with tongue cancers in the oral cavity compared with cancer-free controls. We conducted a case–control study in a tertiary care cancer hospital in Chennai, South India. Cases (N = 31) were those with newly diagnosed, pretreatment, biopsy-confirmed, early-stage (<4 cm size) tongue cancers, further classified as early-onset [diagnosed at 20–49 years (N = 12)] or late-onset cancers [diagnosed ≥50 years (N = 19)] for secondary exploratory analyses. Cancer-free controls (N = 31) were unrelated and frequency-matched to the cases on age and sex. Bacterial characterization of saliva was performed using 16S rRNA sequencing. Analyses (n = 175 genera) included linear regression for α-diversity, constrained analysis of principal coordinates, permutational multivariable analysis of variance for β-diversity, and analysis of compositions of microbiomes with bias correction for taxa abundance. We also examined differences in established bacterial pathogens selected a priori. The median age of participants was 52 years, and a third were women. Although there was no difference in α-diversity, β-diversity showed distinct clustering of bacterial genera in controls, early-onset, and late-onset cases. In overall and early-onset cases (vs. controls), genera Eikenella and Campylobacter showae were enriched. Furthermore, in early-onset cases (vs. controls), genera Alloprevotella, Comamonas, and Aggregatibacter were enriched, Oribacterium was depleted, and W5053 had differentially absent patterns. Beyond the established pathogens, this study offers important leads for future etiologic investigations, particularly in exploratory analyses of early-onset tongue cancers in the oral cavity. Prevention Relevance:This pilot study identified differences in overall microbiota and specific bacteria between cancer-free controls and tongue cancer cases in the oral cavity, specifically for early-onset cancers. The identified bacteria, including novel ones, can further be studied as salivary biomarkers for early-onset tongue cancers and to determine causality for prevention.

  • Open Access

    Supplemental Table 1 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study

    by Krithiga Shridhar, Arvind Krishnamurthy, Vijayalakshmi Ramshankar, Siddhartha Mandal, Toral Vaishnani, Spandan Chaudhary, Aastha Aggarwal, Rupak Shivakoti

    Supplemental Table 1. Participants’ characteristics of early- and late-onset tongue cancer cases and cancer-free controls.

  • Open Access

    Supplemental Table 2 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study

    by Krithiga Shridhar, Arvind Krishnamurthy, Vijayalakshmi Ramshankar, Siddhartha Mandal, Toral Vaishnani, Spandan Chaudhary, Aastha Aggarwal, Rupak Shivakoti

    Supplemental Table 2. Unadjusted and adjusted β-coefficient estimates with 95% confidence intervals (CI) of α-diversity by case control.

  • Oral microbiota in early- and late-onset tongue cancers: A pilot case-control study

    by Krithiga Shridhar, Arvind Krishnamurthy, Vijayalakshmi Ramshankar, Siddhartha Mandal, Toral Vaishnani, Spandan Chaudhary, Aastha Aggarwal, Rupak Shivakoti

    Evidence for the role of oral microbiota in tongue cancers is limited despite early-onset and unexplained etiology. We assessed oral microbiota profiles in saliva among participants with tongue cancers in the oral cavity compared to cancer-free controls. We conducted a case-control study in a tertiary care cancer hospital in Chennai, South India. Cases (N=31) were newly diagnosed, pre-treatment, biopsy-confirmed, early-stage (<4 cm size) tongue cancers; further classified as early-onset (diagnosed at 20-49 years (N=12)) or late-onset cancers (diagnosed ≥50 years (N=19)), for secondary exploratory analyses. Cancer-free controls (N=31) were unrelated, and frequency matched to the cases on age and sex. Bacterial characterization of saliva was performed using 16S rRNA sequencing. Analysis (n=175 genera) included linear regression for α-diversity, constrained analysis of principal coordinates, permutational multivariable analysis of variance for β-diversity, and analysis of compositions of microbiomes with bias correction for taxa abundance. We also examined differences in established bacterial pathogens selected a priori. The median age of participants was 52 years and a third were women. While there was no difference in α-diversity, β-diversity showed distinct clustering of bacterial genera in controls, early-onset, and late-onset cases. In overall and early-onset cases (vs. controls), genera Eikenella and Campylobacter showae were enriched. Further, in early-onset cases (vs. controls), genera Alloprevotella, Comamonas, Aggregatibacter were enriched, Oribacterium was depleted, and W5053 had differentially absent patterns. Beyond the established pathogens, this study offers important leads for future etiological investigations, particularly in exploratory analyses of early-onset tongue cancers in the oral cavity.

  • Open Access

    Validation of a novel NGS based BCR::ABL1 kinase domain mutation detection assay in Indian cohort

    by Pooja Chaudhary, Spandan Chaudhary, Falguni Patel, Shiv Patel, Toral Vaishnani, Nikha Trivedi, Dhiren Patel, Tushar Sonagara, Ashish Hirapara, Kavisha Vyas, et al.

    The efficacy and treatment outcome of a CML patient are heavily dependent on BCR::ABL1 kinase domain (KD) mutation status. Next-generation sequencing technology is a bright alternative to the previously used sanger sequencing method due to its global presence in diagnostic setups, massive parallel sequencing ability, and far better sensitivity. In the present study, we have demonstrated a new protocol for kinase domain mutation analysis using the next-generation sequencing (NGS) method using the ion torrent sequencing platform. This protocol uses RNA as the starting material, followed by nested PCR to amplify the fusion transcript, which is subsequently used as a template for NGS. Initial validation and comparison of this assay with the sanger sequencing (SS) method yielded 95.23% agreement. CML samples (n = 121) with a failure to TKI response were subjected to this newly developed NGS-based assay to detect KD mutations, from which samples were found to have mutations with a sensitivity ranging from 2.32 to 93.41%. A total of 34.71% of samples (n = 42) were found to be positive for one or more KD mutations, whereas 65.29% of samples (n = 81) were found to be negative. Nine samples out of 42 positive samples, i.e., 21.42%, were found to have compound mutations. This is one of the first studies from India, which includes more than 160 samples and is analyzed by the NGS approach for KD mutation analysis.


  • Acute Myeloid Leukemia and Next-Generation Sequencing Panels for Diagnosis: A Comprehensive Review

    by Spandan Msc Chaudhary, Pooja Msc Chaudhary, Firoz Msc Ahmad, Neeraj Md Arora

    Acute myeloid leukemia (AML) is a genetically heterogeneous clonal disorder characterized by the accumulation of acquired somatic genetic alterations in hematopoietic progenitor cells, which alter the normal mechanisms of self-renewal, proliferation, and differentiation. Due to significant technological advancements in sequencing technologies in the last 2 decades, classification and prognostic scoring of AML has been refined, and multiple guidelines are now available for the same. The authors have tried to summarize, latest guidelines for AML diagnosis, important markers associated, epigenetics markers, various AML fusions and their importance, etc. Review of literature suggests lack of study or comprehensive information about current NGS panels for AML diagnosis, genes and fusions covered, their technical know-how, etc. To solve this issue, the authors have tried to present detailed review about currently in use next-generation sequencing myeloid panels and their offerings.


  • Open Access

    Validation of a method for diosgenin extraction from fenugreek (Trigonella foenum-graecum L.)

    by Spandan A. Chaudhary, Pooja S. Chaudhary, Bakhtiyar A. Syed, Richa Misra, Prashanth G. Bagali, Sara Vitalini, Marcello Iriti

    Background. Diosgenin is a very important plant secondary metabolite and raw material for the drug industry. Plant sources rich in diosgenin include yam (Dioscorea spp.) and fenugreek (Trigonella foenum-graecum L.). A method for diosgenin extraction from yam extracts has previously been validated, but its extraction from fenugreek plants still requires validation. In addition, all available methods require time-consuming additional purification steps. The present study was aimed at developing a low cost, less time-consuming single-step method for diosgenin extraction from fenugreek. Material and methods. This study represents a method developed for diosgenin extraction from fenugreek plants without any additional/supportive purification methods such as chromatography or thin-layer chromatography. Diosgenin yield estimation and purity analysis by HPLC method, along with accuracy and precision analysis, is presented. Results. Five different fenugreek varieties were subjected to a newly developed diosgenin extraction method, and an HPLC chromatogram showed a single peak corresponding to diosgenin. Yield was determined by the standard curve method. Limit of detection (LOD) and limit of quantification (LOQ) for the assay were found to be 0.0312 and 0.102 mu g, respectively; t(calculated) for slope and other statistical parameters were found to be significant (P value < 0.001) for this method. Conclusion. We have developed a fast, accurate and low cost method for diosgenin extraction from fenugreek. Although the authors have studied this method only in fenugreek plants, it could be applied to the extraction of a few other plant secondary metabolites, which will help researchers to save time and effort.


  • Open Access

    Elicitation of Diosgenin Production in Trigonella foenum-graecum (Fenugreek) Seedlings by Methyl Jasmonate

    by Spandan Chaudhary, Surendra K. Chikara, Mahesh C. Sharma, Abhinav Chaudhary, Bakhtiyar Alam Syed, Pooja S. Chaudhary, Aditya Mehta, Maulik Patel, Arpita Ghosh, Marcello Iriti

    The effects of methyl jasmonate (MeJA), an elicitor of plant defense mechanisms, on the biosynthesis of diosgenin, a steroidal saponin, were investigated in six fenugreek (Trigonella foenum-graecum) varieties (Gujarat Methi-2, Kasuri-1, Kasuri-2, Pusa Early Branching, Rajasthan Methi and Maharashtra Methi-5). Treatment with 0.01% MeJA increased diosgenin levels, in 12 days old seedlings, from 0.5%–0.9% to 1.1%–1.8%. In addition, MeJA upregulated the expression of two pivotal genes of the mevalonate pathway, the metabolic route leading to diosgenin: 3-hydroxy-3-methylglutaryl-CoA reductase (HMG) and sterol-3-β-glucosyl transferase (STRL). In particular, MeJA increased the expression of HMG and STRL genes by 3.2- and 22.2-fold, respectively, in the Gujarat Methi-2 variety, and by 25.4- and 28.4-fold, respectively, in the Kasuri-2 variety. Therefore, MeJA may be considered a promising elicitor for diosgenin production by fenugreek plants.